World EPA Congress

Alongside the conference tracks, the event includes an exhibition and built-in networking designed to connect delegates with solution providers and peers working across evidence generation and access decision-making.

Who the audience is and how many attend

Audience

• Market access, pricing and reimbursement leaders in pharma and biotech
• HEOR and real-world evidence (RWE) professionals responsible for value strategy and evidence generation
• Payers and HTA bodies, plus policy and public affairs stakeholders
• Consultants, data/analytics teams and solution providers supporting access and evidence functions

Scale

• Delegates: 1,500+
• Speakers: 250+
• Tracks: 10
• Exhibitors: 120+

What to expect

• A multi-track agenda spanning access, pricing, reimbursement, HTA and HEOR/RWE themes
• Practical discussion with senior speakers from pharma, biotech and payer/HTA organisations
• A sizeable exhibition featuring solution providers across evidence generation, market access and pricing
• High-density networking across both days, including structured 1:1-style connection opportunities